FDA Approves Bayer’s Nubeqa for Wider Use in Prostate Cancer Subtype.
In combination with docetaxel, the U.S. Food and Drug Administration (FDA) has approved Bayer’s Nubeqa for the treatment of hormone-sensitive metastatic prostate cancer (mHSPC).Nubeqa (darolutamide) was previously approved for the treatment of non-metastatic castration-resistant prostate ... [Read]
Copper Demand Expected to Nearly Double by 2035
Copper supply can’t keep up with the booming demand for copper, putting net-zero emissions targets at risk, according to a new report from S&P Global. Copper is essential for electric vehicles, wind and solar power, ... [Read]
US Tax Credit Could Rev Up Electric Vehicle Production In Canada
Canadian car makers breathed a sigh of relief last week when US lawmakers decided to scrap part of a large incentive package for electric vehicles (EVs) that originally excluded EVs assembled in Canada from a ... [Read]
Vietnam Is Featured by Radisson Hotel Group’s Expanding National Portfolio
Radisson Hotel Group (AB:RADH) expects to quadruple its presence in Vietnam by 2025 by building a dedicated representative office and considerably expanding its portfolio of properties in the country. This extensive growth strategy will enable ... [Read]
Semtech Confirms the Acquisition of Sierra Wireless for $1.2 Billion.
Sierra Wireless (NASDAQ:SWIR) will be acquired by Semtech (NASDAQ:SMTC) for $31 per share in cash. This gives Sierra Wireless an enterprise value of $1.2 billion. The $31 offer represents a roughly 25% premium above Sierra ... [Read]
Talos Energy Has Begun Negotiations to Acquire Enven for $1 Billion.
Talos (NYSE:TALO) is also considering EnVen’s $288 million in debt at the end of 2021. Talos (NYSE:TALO) Energy is in early negotiations to acquire EnVen (NYQ:ENVN), which owns oil and gas properties in the Gulf ... [Read]
Senate Bill Targets Credit Card Fees for Visa and Mastercard
Two U.S. senators are drafting legislation that would allow retailers to handle a large number of Visa Inc. and Mastercard Inc. credit cards via multiple networks. The plan, which might be proposed as early as ... [Read]
The Phase 1b study by Aligos Therapeutics to assess its Class II Capsid Assembly modulator, ALG-000184, started with a 12-week dosing cohort.
The clinical-stage biopharmaceutical company Aligos Therapeutics, Inc. (Nasdaq:ALGS), which focuses on creating novel treatments for unmet medical needs in viral and liver diseases, announced today that enrollment in a 12-week dosing cohort of HBeAg-positive chronic ... [Read]
In a year of turnaround, Sundial Growers will split stock.
At 41 cents per share, the Sundial Growers (SNDL) stock price is significantly below Nasdaq’s minimum continued listing requirement of $1 per share. And both of the company’s grace periods for bringing the share price ... [Read]
Emergent executes a letter of intent to acquire Evolutionary Biologics; former L’Oréal president Jim Morrison will become Emergent’s full-time chief executive officer.
Emergent Health Corp. (“Emergent”) (OTC PINK:EMGE) announces it has executed a Letter of Intent to acquire Evolutionary Biologics, Inc. Biologics, Inc. is a new type of biologics company with a specific mission: to provide the ... [Read]